ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,939 | -28.8% | 86,291 | 0.0% | 0.21% | -26.7% |
| Q2 2023 | $557,440 | -14.3% | 86,291 | 0.0% | 0.28% | -14.1% |
| Q1 2023 | $650,634 | -25.6% | 86,291 | 0.0% | 0.33% | -31.3% |
| Q4 2022 | $874,128 | +2.5% | 86,291 | 0.0% | 0.48% | +13.3% |
| Q3 2022 | $853,000 | -27.2% | 86,291 | -21.6% | 0.42% | -8.7% |
| Q2 2022 | $1,172,000 | +31.8% | 110,047 | +20.7% | 0.46% | +89.3% |
| Q1 2022 | $889,000 | -32.7% | 91,200 | -1.3% | 0.24% | +3.4% |
| Q4 2021 | $1,321,000 | -53.9% | 92,358 | -35.4% | 0.24% | -20.6% |
| Q3 2021 | $2,865,000 | – | 142,970 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |